Last reviewed · How we verify
NCT07107542
Exploring the Relationship Between Mini-Clinical Evaluation Exercise (Mini-CEX) and Entrustable Professional Activities (EPAs) in Occupational Therapy Clinical Interns' Independent Competence
trial testing Mini-Clinical Evaluation Exercise (Mini-CEX) and Entrustable Professional Activities (EPAs) Assessment in Entrustable Professional Activities in 50 participants. Not yet recruiting.
30 December 2028
Quick facts
| Lead sponsor | Far Eastern Memorial Hospital |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 50 |
| Start date | 8 October 2025 |
| Primary completion | 30 December 2028 |
| Estimated completion | 30 March 2029 |
| Sites | 1 location across Taiwan |
Drugs / interventions tested
- Mini-Clinical Evaluation Exercise (Mini-CEX) and Entrustable Professional Activities (EPAs) Assessment
Conditions studied
- Entrustable Professional Activities — all drugs for Entrustable Professional Activities →
- Mini-clinical Evaluation Exercise — all drugs for Mini-clinical Evaluation Exercise →
- Physical Occupational Therapy — all drugs for Physical Occupational Therapy →
- Occupational Therapy Education — all drugs for Occupational Therapy Education →
Sponsor
Far Eastern Memorial Hospital
Who can join
Adults 18 to 35, any sex, with Entrustable Professional Activities or Mini-clinical Evaluation Exercise. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this observational cross-sectional study is to evaluate whether the combined use of Mini-Clinical Evaluation Exercise (Mini-CEX) and Entrustable Professional Activities (EPAs) can assess the independent clinical competence of occupational therapy interns at Far Eastern Memorial Hospital. The main questions it aims to answer are: 1. Does the performance on Mini-CEX correlate with the interns' ability to perform independently? 2. Does the use of EPAs provide additional insight into interns' readiness for unsupervised clinical practice? Participants will: 1. Provide informed consent at the sixth week of their internship. 2. Undergo assessment with Mini-CEX and EPAs during their eighth week of clinical training. 3. Complete demographic questionnaires including age, gender, study habits, prior university experience, parental occupation, and residence area.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07107542
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Far Eastern Memorial Hospital trials
Trials by the same sponsor.
- NCT07385976 — The Role of Blood Perfusion in Cervical Cancer, Cervical Intraepithelial Neoplasm and Ovarian Cancer Patients · not yet recruiting
- NCT07105345 — Exploring Efficacy of Multi-Mode Cognitive Processing Therapy (CPT) for PTSD · NA · recruiting
- NCT07114653 — The Role of POLE Mutation in High Risk Endometrial Cancer. · recruiting
- NCT07110350 — Clinical Outcomes of Non-Indicated Staged Laparotomies in Abdominal Trauma · not yet recruiting
- NCT07114640 — The Effect of Nighttime Mirabegron, Solifenacin, Tolterodine, or Oxybutynin on Nocturia, Sexual Function, Autonomic Func · Phase 3 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07107542 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Far Eastern Memorial Hospital
- Last refreshed: 6 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07107542.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing